tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Silexion Therapeutics completes toxicology studies for SIL204
PremiumThe FlySilexion Therapeutics completes toxicology studies for SIL204
21d ago
Silexion Therapeutics reports Q3 EPS $2.88 vs $274.25 last year
Premium
The Fly
Silexion Therapeutics reports Q3 EPS $2.88 vs $274.25 last year
1M ago
Silexion Therapeutics files to sell 1.29M ordinary shares for holders
Premium
The Fly
Silexion Therapeutics files to sell 1.29M ordinary shares for holders
2M ago
Silexion Therapeutics Enters Market Offering Agreement
PremiumCompany AnnouncementsSilexion Therapeutics Enters Market Offering Agreement
3M ago
Silexion Therapeutics regains compliance with Nasdaq listing requirements
Premium
The Fly
Silexion Therapeutics regains compliance with Nasdaq listing requirements
3M ago
Silexion Restores Nasdaq Compliance After Strategic Moves
Premium
Company Announcements
Silexion Restores Nasdaq Compliance After Strategic Moves
3M ago
Why Is Silexion Therapeutics Stock (SLXN) Up 190% Today?
PremiumMarket NewsWhy Is Silexion Therapeutics Stock (SLXN) Up 190% Today?
3M ago
Silexion Therapeutics Reveals Positive Preclinical Data for SIL204
Premium
Company Announcements
Silexion Therapeutics Reveals Positive Preclinical Data for SIL204
3M ago
Silexion Therapeutics announces preclinical data on SIL204
Premium
The Fly
Silexion Therapeutics announces preclinical data on SIL204
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100